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Abstract
Background: Highly efficient genome editing can be achieved through targeting an endonuclease to specific locus
of interest. Engineered zinc-finger nuclease (ZFN) and CRISPR-associated protein-9 nuclease (Cas9) offer such an
elegant approach for genome editing in vertebrate cells. In this study, we have utilized ZFN and Cas9-catalyzed
double strand break followed by homologous recombination-mediated incorporation of premature stop codon and
selection marker to target human cell division cycle 14A (hCDC14A) and cell division cycle 14B (hCDC14B) genes.
Results: Targeting of the hCDC14A and hCDC14B loci in telomerase immortalized human retinal pigment
epithelium (hTERT-RPE1) and human colon cancer (HCT116) cells were confirmed by Southern blot hybridization.
Nevertheless, DNA sequence analysis of reverse transcription polymerase chain reaction (RT-PCR) products
confirmed that in all the single/double allele ablations, the targeted exon was spliced out. The phenomenon of
exon skipping was independent of the genome editing approaches exploited, Cas9 or ZFN. Because the exons had
a nucleotide number that could be divided by 3, the reading frame of the exon deletion was maintained. This
indicates an exon-skipping event possibly due to the insertion of large DNA fragment (1.7 to 2.5 Kb) within the
targeted exons. As a proof-of-principle, we have used gene disruption followed by non-homologous end joining
(NHEJ) approach. Small alterations in the exon (one to fifteen bases) were transcribed to mRNA without exon
skipping. Furthermore, loxP site-mediated removal of selection markers left a 45 bp scar within the targeted exon
that can be traced in mRNA without exon skipping.
Conclusion: From this study, we conclude that insertion of a large DNA fragment into an exon by genome
editing can lead to its skipping from the final transcript. Hence, more cautious approach needs to be taken
while designing target sites in such that the possible skipping of targeted exon causes a frame-shift mediated
incorporation of pre-mature stop codon. On the other hand, exon skipping may be a useful strategy for the
introduction of protein deletions.
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Background
Highly dynamic, yet tightly controlled, protein phos-
phorylation and de-phosphorylation events are import-
ant avenues to tweak cell cycle transition processes.
Cyclin-dependent kinases (CDKs) lie at the heart of cell
cycle control system and their activities rise and fall as
the cell progresses through the cell cycle (Reviewed in
[1]). In budding yeast Saccharomyces cerevisiae, the
highly conserved ScCdc14 (cell division cycle 14 gene)
phosphatase antagonizes the Cdk1 functions to allow
anaphase regulation and mitotic exit [2]. Human cells
encode three paralogs of hCDC14 namely hCDC14A,
hCDC14B and hCDC14C [3, 4]. In spite of the high con-
servations between the catalytic domain of all CDC14
phosphatases [5] and the complementation of ScCdc14
by hCDC14B [6], human CDC14s have so far been re-
ported to be involved in functions that are quite diverse
than that of budding yeast [7]. Human hCDC14A was
proposed to exert its function at centrosome duplication
[8] while hCDC14B was implicated in mitotic progres-
sion [9], DNA damage checkpoint activation and DNA
repair [10]. Nevertheless, hCDC14B depleted human
cells display normal mitotic exit and cytokinesis [11].
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Moreover, the viability of hCDC14A or hCDC14B single
knockout (KO) vertebrate cells [12] indicate the possible
functional redundancy of vertebrate phosphatases. It is
noteworthy that most of the previously reported func-
tions of hCDC14A/B were deduced upon siRNA deple-
tion (often without a rescue experiment) or strong over-
expression that causes toxic effects. Extent of depletion
as well as the functional redundancy of the phosphatases
was not taken into consideration partly because of the in-
ability of available antibodies to recognize endogenous
hCDC14A and hCDC14B proteins [12–14].
Genome editing provides an alternative strategy to
siRNA depletion for hCDC14A and hCDC14B inactiva-
tion. Currently, several strategies exploiting sequence-
specific endonucleases exist for purposeful genome edit-
ing, including Zinc-finger nuclease (ZFN), transcription
activator-like effector nuclease (TALEN), and the RNA-
guided clustered regularly interspaced short palindromic
repeats (CRISPR)-Cas9 nuclease system [15]. In all these
approaches, an endonuclease is programmed to specific-
ally bind the assigned nucleotide sequence and trigger sin-
gle or double strand breaks (DSB). Cells can take either
high-fidelity homologous recombination (HR) and/or
error-prone non-homologous end-joining (NHEJ) to re-
pair this DSB [16] (Additional file 1: Figure S1). NHEJ
might alter the DSB site by random insertion or deletion
of nucleotides of varying length. On the other hand, hom-
ologous recombination can be utilized to deliberately
introduce stop codons and selectable markers for ensuring
genome disruption (Additional file 1: Figure S1).
In this study, we have used DSB-enhanced HR event to
incorporate pre-mature stop codons followed by selection
markers (~2 kb sizes) within the selected exons of human
hCDC14A and hCDC14B genes. Nonetheless, Cas9 and
ZFN-mediated genome disruption strategies have unfolded
complications owing to the in-frame skipping of targeted
exons. We presume that interruption due to the incorpor-
ation of a large fragment of DNA (1.7 to 2.5 kb including
stop codon and selection markers) has structural effects on
exon definition as reviewed by Valentine [17]. LoxP site-
mediated removal of selection markers from the previously
generated knockins prevented exon skipping but left a
45 bp Stop-loxP scar within the targeted exon. Thus, we re-
port that insertion of large DNA fragment into an exon by
genome editing leads to its skipping from the final tran-
script and how this property can be used in genome
editing.
Results and discussion
Disruption of the hCDC14A and hCDC14B loci in human
somatic cells
We have utilized CompoZrTM ZFNs, designed and evalu-
ated by Sigma Advanced Genetic Engineering Labs, to
make hCDC14A and hCDC14B knockouts in two human
cell lines (hTERT-RPE1 and HCT116) with stable geno-
type. ZFN-induced homologous recombination strategy
was employed to incorporate premature stop codon and
selection markers (neomycin or puromycin) into the tar-
geted exons of hCDC14A (9th exon) and hCDC14B (4th
exon) (Fig. 1a, b). Southern blot analysis has confirmed
the successful biallelic targeting of the hCDC14A and
hCDC14B loci by NeoR or PuroR cassettes (Fig. 2a-c).
RT-PCR analysis confirming expression of wild type and
in-frame exon-skipped hCDC14A/ hCDC14B transcripts
Sequencing of the hCDC14A and hCDC14B RT-PCR (re-
verse transcriptase polymerase chain reaction) products
from wild type and selection marker knockins verified the
presence of exon-skipped mature mRNA in the targeted
hCDC14A and hCDC14B clones (Fig. 3a, b). The reading
frames remain intact as the skipped exons in both the
cases (9th exon for hCDC14A and 4th exon for hCDC14B)
contained nucleotide number that could be divided by
three. Hence, we have to assume the presence of truncated
hCDC14A and hCDC14B proteins.
The 9th exon of hCDC14A includes the active site cyst-
eine and aspartate residues necessary for phosphatase ac-
tivity [5, 18, 19], suggesting the inactivation of hCDC14A
phosphatase from these cell lines. Conversely, the catalyt-
ically important residues for hCDC14B are located in 9th
exon, downstream to the targeted exon [5]. Thus, in case
of hCDC14B the gene interference strategy most likely
creates a small truncation of 31 amino acids in the
hCDC14B protein that might not affect phosphatase
activity.
Exon-skipping phenomenon is independent of genome
editing approach
Our ZFN-mediated genome editing of hCDC14A and
hCDC14B has clearly indicated the skipping of tar-
geted exon from the final transcript. As a faster and
more affordable alternative to ZFN, there is a recent
surge in use of CRISPR-Cas9 system for genome edit-
ing. We have taken the advantage of CRISPR-Cas9
system to target hCDC14A locus with the same donor
construct and guide RNA that targets the same gen-
omic hCDC14A DNA sequence as the ZFN. As the
lengthy custom design of the ZFN was avoided,
CRISPR-Cas9 strategy was clearly faster and more
than 50-fold cost-efficient than the ZFN approach. As
anticipated, we observed exon skipping in HCT116
and RPE1 cells in which hCDC14A was targeted by
CRISPR-Cas9 (Fig. 4, Additional file 2: Figure S2).
This further implies that the skipping event is associ-
ated with the degree of exon alteration not merely a
random outcome of genome editing approach.
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Minimizing the degree of alteration salvages the exon
skipping
As a cause of exon skipping, we hypothesized that large
insertion-mediated alteration of the targeted exon affects
the pre-mRNA structure [17]. Hence, to avoid large-
scale genome editing, we have taken two experimental
strategies. First, genomic loci were targeted by the same
ZFNs but with error-prone NHEJ, with the view in mind
to have random smaller insertions or deletions (Fig. 5a).
Secondly, the selection markers flanked by loxP sites
were removed by Cre-recombinase to generate loci with
45 base pair insertions including stop codons immedi-
ately followed by the single loxP site (Fig. 5b). In both
the cases, sequencing of genomic loci indicated the ex-
pected abruptions. Similarly, sequencing of the RT-PCR
products confirmed the likewise modifications within
the targeted exons without their skipping from the ma-
ture transcript (Fig. 5a, b).
Semi-quantitative RT-PCR using GAPDH as a control
indicated that the exon-skipped hCDC14B mRNA level
was less than half of the wild-type mRNA (Fig. 5c). Such
decrease in mRNA level might be due to transcriptional
control (altered synthesis) and/or post-transcriptional
regulation (altered stability) of disrupted cellular tran-
scripts. Because of the lack of anti-hCDC14B antibodies
that detect the endogenous proteins [12–14], we were un-
able to confirm this mRNA decrease at the protein levels.
Taken together, we describe that insertion of a rela-
tively large DNA fragment into an exon can cause exon
skipping. If the exon has a length that can be divided by
3, this leads to an in-frame fusion between the alternat-
ing exons. In case of hCDC14A, the truncated gene
product lacks phosphatase activity because the deleted
exon 9 contains the active site cysteine residue. Since
phosphatases can have a scaffold function [20], analysis
of this hCDC14A-Cys mutant can be used to uncover
such a role. In contrast, deletion of the exon 4 of
hCDC14B most likely results in a small truncation in
the N-terminus of hCDC14B away from the nucleolar
targeting sequence [7]. Since the residues required for
Fig. 1 Strategy for ZFN-mediated generation of knockout cell lines. a Exon 9 of hCDC14A was targeted by zinc finger nuclease (ZFN). A donor template
containing two homologous arms (HA), stop codon and neomycin selection cassette was used for their homologous recombination mediated insertion
within the double strand break (DSB) site. Junction PCR with forward primer (blue arrow) in NeoR cassette and reverse primer (red arrow) in the genome
outside homology arm confirmed successful targeting and insertion of the selection marker. b Exon 4 was targeted to knockout hCDC14B gene. As donor
template for hCDC14A, neomycin selection cassette was used to generate hCDC14B single knockout. Puromycin cassette was used when hCDC14B was
knocked-out on top of hCDC14A−/− cells (neomycin). Forward (blue) and reverse (red) primers used for the junction PCR are shown in the figure
Uddin et al. BMC Genomics  (2015) 16:1082 Page 3 of 10
hCDC14B activity were not affected, it is likely that this
truncation does not affect the activity of the phosphatase.
However, removal of the selection marker by Cre-induced
recombination prevented exon skipping and disrupted
gene function by introducing stop codons. Thus,
adenovirus-Cre mediated infection of hCDC14B::neomy-
cin cells can be used to introduce an acute knockout of
hCDC14B function.
Conclusion
Genome editing is a robust experimental paradigm to as-
sign cellular function(s) to a molecule. Simplicity of genome
editing through engineered nucleases has recently allured
the scientific community to generate knockout cellular
models. Utilizing selection markers greatly augments the
ease of generating knockout cellular clones. However, our
study clearly shows that, the selection marker also imposes
an inherent size-associated mRNA processing difficulty of
the targeted exon. In most of the cases, the selection
markers overweigh the average length of eukaryotic exon
(<200 bp, [21, 22]). For example, the 4th exon of hCDC14B
is 93 bases long compared to the 1.7 kb of neomycin and
2.5 kb of puromycin cassette. Such massive alterations have
the potential to annihilate secondary pre-mRNA structure
and impede cellular mRNA processing leading to exon
skipping. Well-informed and pre-planned experimental
choices should be made to target the suitable exon while
editing the genome of higher eukaryotes like in human
cells. An alternative strategy could be the introduction of
double strand break in an intronic sequence to incorporate
homologous recombination mediated subtle changes in the
adjacent exon. These exon modifications could be intro-
duced in the donor along with the selection marker. Of
note, such skipping mechanisms can be useful to engineer
proteins with small deletions or for the analysis of acute
knockouts in response to Cre - induced selection marker
removal.
Methods
Generation of ZFN-mediated knockout cells
Human CDC14A and CDC14B specific CompoZr™ knock-
out Zinc Finger Nucleases were designed and evaluated by
Fig. 2 Southern blot hybridization to confirm biallelic targeting of hCDC14A and hCDC14B loci in RPE1 cells. a Map for hCDC14A and hCDC14B
genomic locus targeted by zinc finger nuclease (ZFN). The probes for Southern blot hybridization were designed in the right homologous arms
(shown as green bar). In case of hCDC14A, digestion by Hind III would result in a 2.9 kb fragment for knockout cells instead of wild-type 1.2 kb band.
For knocking out hCDC14B, neomycin or puromycin inserted donor templates were used. Puromycin construct (with an extra Hind III site) was used
when hCDC14B knocking out was carried out on top of hCDC14A−/− cells (NeoR) (double knockout). On the other hand, neomycin construct was used
during generation of single hCDC14B knockout. b Southern blot hybridization to confirm hCDC14A knockout (AKO) with a hCDC14A specific probe (a).
The expected hCDC14A band sizes were observed for wild type (Wt, 1.2 kb), hCDC14A single (AKO) and hCDC14A hCDC14B double knockouts (DKO)
(2.9 kb). c Southern blot hybridization to confirm hCDC14B knockout (BKO) with a hCDC14B specific probe (a). The DKO (see a, PuroR) and Wt cells have
shown anticipated band sizes of 3.2 kb and 4.0 kb, respectively. For single hCDC14B knockouts (BKO), two extra bands above and below the
expected band size of 5.7 kb (asterisks) was persistently observed in different clones. Absence of wild type bands (4.0 kb) in these knockouts confirmed
the successful targeting of both alleles
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Sigma Advanced Genetic Engineering Labs. The ZFN for
hCDC14A (product Number: CKOZFND2170-1KT) tar-
gets the sequence 5′-AGCACACCCAGTGACaacatCGT
GCGAAGGTTCCTGAA-3′ in the 9th exon (cutting site
in lower cases). Target sequence for ZFN against hCDC14B
is in the 4th exon 5′-TGCTGCCTTCCTTGTtggatGCTA
CATGGTAAGTATTTG-3′ (product Number: CKOZFN
D5769-1KT).
The donor vector was constructed by PCR amplifica-
tion of the genomic locus as reported by Panic et al.
[23]. In short, the genomic locus 800 bp upstream and
downstream of the ZFN cut site was amplified and sub-
cloned into pJet 1.2 vector. The insertion cassette in-
cluding STOP codon in every frame and neomycin/
puromycin resistance was inserted at the cut site of
donor vector.
106 cells were co-transfected with the ZFN mRNAs
(2.5 μg of each) and donor vector (7 μg) by electropor-
ation (Invitrogen, Neon transfection system). After elec-
troporation, cells were cultured for 24 h at 37 °C
(recovery) followed by 48 h at 30 °C (enhancing ZFN ef-
ficiency [24]). Cells were further cultured at 37 °C for
72 h prior to single cell dilution (limiting) in 96 well
plates (500 μg/ml neomycin). Two weeks later, the emer-
ging clones were screened by genomic PCR and positive
clones were further confirmed by RT-PCR as well as
southern blot hybridization. Junction PCR with one pri-
mer in donor construct and the other in the genome
outside homology arm confirmed successful targeting
and insertion of the selection markers. The following
primers were used for junction PCR - hCDC14A: for-
ward 5′-CGGCTATGACTGGGCACAAC-3′; reverse
Fig. 3 RT-PCR analysis to confirm expression of wild type and exon-skipped transcripts. Gel images for RT-PCR products of hCDC14A (a) and hCDC14B
(b) transcripts from wild type (Wt) and knockout cells (KO). Maps show the locations of primers (black arrows) used for PCR reaction. The generated
DNA bands were gel purified and sequenced. Sequences of alternating exon junctions are shown in the respective lower panels (exon 8 to 10 in case
of hCDC14A and exon 3 to 5 for hCDC14B). In-frame exon skipping can be deduced from the amino acid sequences written above the codons
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5′- GCCTCCTCGAAGTCAAACAAG −3′; hCDC14B
(for NeoR insertion): forward 5′-CGGCTATGACTGGG
CACAAC-3′; reverse 5′-CGATCTCCGCTCACTG-3′;
hCDC14B (for PuroR insertion): forward 5′-CGGGGCG
AAGGCAAC-3′; reverse 5′-CGATCTCCGCTCACTG-3′.
Similar approach without the donor construct was taken in
case of NHEJ-facilitated disruption of hCDC14B gene. The
resultant insertion/deletion-mediated mutagenesis was
Fig. 4 Strategy for Cas9-mediated generation of hCDC14A knockout HCT116 cells. a, b Workflow for CRISPR-Cas9 medicated insertion of NeoR into
exon 9 of hCDC14A. Guide RNAs (gRNAs) targeting the exon 9 of hCDC14A gene were designed using the web tool (http://crispr.mit.edu/ [25]).
‘Churh gRNA insert’ containing the U6 promoter and gRNA scaffold [26] was first synthesized as gBlock and cloned into pJet. The intended gRNAs
were inserted through PCR mutagenesis using primers indicated by arrows (top of b). The same donor construct (bottom of b) as in case of
ZFN-mediated genome editing was used to target the locus. c Junction PCR (as in Fig. 1a) with forward primer in NeoR cassette and reverse
primer in the genome outside homology arms confirmed successful targeting and insertion of the selection marker.d RT-PCR of purified mRNA
from Wt and different CRISPR-Cas9 targeted hCDC14A-KO clonal cells. Primers were as in Fig. 3a. Presence of both wild type and exon-skipped
RNA indicated the targeting of single allele in clone 17. The other NeoR clones 7, 15 and 19 contained bi-allelic knockout of the hCDC14A gene. e
The generated DNA bands of the RT-PCR were gel purified and sequenced. Sequences of alternating exon junctions of hCDC14A are shown and
in-frame exon skipping can be deduced from the amino acid sequences written above the codons
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detected by sequencing of the amplified (Q5® High-Fidelity
DNA Polymerase - NEB) genomic locus surrounding the
ZFN cut site (primers used - forward 5′-TGAATGGTTA
TGGGATTTGGA-3′; reverse 5′-GCACAGCTTCCTTG
AATTGG-3′).
Generation of Cas9-mediated knockout cells
Guide RNAs (gRNAs) targeting the exon 9 of hCDC14A
was designed using the web tool (http://crispr.mit.edu/ [25]).
gRNA1 (5′-CCAGTGACAACATCGTGCGA-3′), gRNA2
(5′-CCTTCGCACGATGTTGTCAC-3′) and gRNA5
Fig. 5 Exon skipping can be abolished by minimizing the degree of alteration. a Exon 4 of hCDC14B was targeted by ZFN to introduce double strand
break (DSB) and error-prone NHEJ for random insertion and deletion. In some of the targeted loci, small alterations in the exon (one to fifteen bases) were
observed. ZFN cutting sites are written in blue font and base deletions or insertions are marked by red font color. Sequencing of the RT-PCR products
confirmed identical base pair changes without exon skipping (sequence not shown). b The selection cassette flanked by loxP sites was removed by
Cre-recombinase from HCT116 and RPE1 hCDC14B-KO cells. RT-PCR analysis confirmed the presence of stop codon (11 bp) followed by one loxP site
(34 bp) within the targeted exon in both the cell lines. c Semi-quantitative RT-PCR indicated that the exon-skipped mRNA level of RPE1 cells is less than half
of the wild-type mRNA. 40 ng of total RNA was used and the input RNA level was confirmed by GAPDH amplification as mentioned by Carbery et al. [30].
The experiment was performed three times with similar outcome. One representative experiment is shown. The numbers below the agarose gel
summarizes the relative abundance of the mRNA from three different experiments
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(5′-CTTCGCACGATGTTGTCACT-3′) with scores
96, 91 and 86, respectively, were selected as they were
exactly targeting the ZFN binding site (5′-AGCACACC
CAGTGACaacatCGTGCGAAGGTTCCTGAA-3′).
‘Churh gRNA insert’ containing the U6 promoter and
gRNA scaffold [26] was first synthesized as gBlock from IDT
(http://www.idtdna.com/pages/products/genes/gblocks-
gene-fragments) and cloned into pJet1.2 vector. The
intended gRNAs were then ordered as PCR primers with
overhangs from U6 promoter and gRNA-scaffold and
inserted between U6 promoter and gRNA scaffold through
PCR mutagenesis (Fig. 4).
Different strategies were used to generate hCDC14A-
KO HCT116 and RPE1 cells. For HCT116, hCas9 plasmid
(a gift from George Church (Addgene # 41815, [26])) was
transiently transfected with gRNA and donor plasmids.
Whereas for RPE1 cells, pCW-Cas9 plasmid (a gift from
Eric Lander & David Sabatini (Addgene # 50661 [27]))
containing doxycycline (Dox) inducible spCas9 was lenti-
virally integrated into RPE1 FRT/T-Rex cells. Successful
expression and nuclear localization of Cas9 was confirmed
by indirect immunofluorescence and western blot analysis
(Additional file 2: Figure S2). The cells were then electropo-
rated with the plasmids containing gRNA and donor vector
as showed in Fig. 4b. Junction PCR with forward primer in
NeoR cassette (5′-CGGCTATGACTGGGCACAAC-3′)
and reverse primer in the genome outside homology arms
(5′-GCCTCCTCGAAGTCAAACAAG-3′) confirmed suc-
cessful targeting and insertion of the selection marker.
Southern blot hybridization to confirm knockouts
Genome editing in both RPE1 and HCT116 cells was
verified by Southern blot hybridization [28]. Genomic
DNA was isolated using MasterPure DNA purification
kit (Epicentre, Cat MCD85201) following manufactures
instructions. 20 μg of DNA were digested overnight with
FastDigest Hind III-HF (Thermo Scientific) and run
overnight onto a long (18 cm) 0.8 % agarose gel at 30–
35 V. The gel was subsequently stained and photo-
graphed (fluorescent ruler of gel-casting tray was used
to track the distance of migration of DNA bands). The
gel was then washed in double distilled water (ddH2O)
and DNA was denatured in 0.5 M NaOH, 1.5 M NaCl
(twice for 20 min with gentle shaking). After rinsing
once with ddH2O, DNA was neutralized by washing
thrice for 15 min with 1.5 M NaCl, 0.5 M Tris–HCl
(pH 7.0) and transferred onto a GeneScreen Plus®
Hybridization Transfer Membrane (PerkinElmer) by
overnight capillary transfer in 10xSSC buffer (1.5 M
NaCl, 0.15 M trisodium citrate). After rinsing the mem-
brane with 2XSSC buffer, DNA was UV-crosslinked with
a Stratalinker 1800 (Stratagene).
The membrane was hybridized over night in DIG Easy
Hyb buffer (Roche, cat#11603558001) with DIG labeled
probe generated by PCR DIG probe Synthesis kit (Roche,
cat#11636090910). Primers used to generate DIG probes
for hCDC14A: forward 5′-CATCGCCGTTCACTGC-3′,
reverse 5′-ACGTGGGCCTGGAAAG-3′; and hCDC14B:
forward 5′-GCCCAACTACTTTGGCAAAG-3′, reverse
5′- CCAATGATCCAAATGGAGCAC-3′.
RNA preparation from cells and expression analysis
Total RNA was isolated from cells using the RNeasy
Mini Kit (Qiagen, Hilden, Germany) following manufac-
turers protocol. RT-PCR analysis confirming expression
of wild type and exon-skipped hCDC14A/B transcripts
were carried out using SuperScript® III One-Step RT-
PCR System with Platinum® Taq DNA Polymerase (Invi-
trogen). Forward primer binding to 8th exon (5′-
ATGGTGACTTCAACTGGA-3′) and reverse primer
binding to 10th exon (5′-CTTCCAGGAAGTGCTGC-
3′) were used for RT-PCR of hCDC14A coding sequence
(CDS). In case of hCDC14B, the forward primer was de-
signed in the 2nd exon (5′-GCCATTCTCTACAGCAG-
3′) while reverse primer in 6th exon (5′-GCAACTTC-
CATAGGCAGC-3′). Bands corresponding to wild type
and exon-skipped clones were excised from the gel and
sequenced to verify the presence of the splice junctions
(hCDC14A: exon 8→ 10; hCDC14B: exon 3→ 5). Hu-
man GAPDH was amplified with the primers described
by Zhang et al. [29]: forward 5′-ATCCCATCAC-
CATCTTCCAG-3′ and reverse 5′-CCATCACGCCA-
CAGTTTCC-3′. For semi-quantitative RT-PCR, 40 ng
of total RNA was used as template and the relative
amount of mRNA in different samples was calculated by
measuring the band intensity (normalized to GAPDH)
using NIH ImageJ software [30] .
Immunofluorescence microscopy and immunoblotting
Cells were seeded on cover slips, allowed to attach and
fixed with ice-cold methanol for 5 min at −20 °C prior
to permeabilization with 0.1 % Triton X-100 for 10 min.
After, blocking with 10 % (v/v) fetal calf serum (FCS) for
30 min, cells were stained with anti-bodies in 3 % (w/v)
BSA (bovine serum albumin) in PBS. Hoechst 33342
(0.2 g/ ml, Calbiochem) was used to visualize nucleus.
The anti-Flag (Cell Signalling, M2) primary antibody
was used to detect 3XFLAG-SpCas9. Imaging was per-
formed on a DeltaVision RT system (Applied Precision)
with an Olympus IX71 microscope using Softworx soft-
ware (Applied Precision).
For immunoblotting, cells were washed twice with PBS
and lysed in lysis buffer (10 mM Tris-Cl pH 7.5, 150 mM
NaCl, 5 mM EDTA, 0.1 % SDS, 1%Triton X-100, 1 %
deoxycholate) supplemented with 1 mM PMSF (Sigma)
and protease inhibitor cocktail (Roche) for 30 min. Lysates
were centrifuged and the supernatant was boiled with
Laemmli buffer. SDS-PAGE was performed as previously
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described [31]. The membranes were blocked in 5 % non-
fat milk in TBS-T and anti- α-tubulin (Sigma, T-9026),
anti-Flag (Cell Signalling, M2) primary antibodies were
used with appropriate secondary antibodies.
Cell culture
hTERT-RPE1 cells were cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM) F12 (Gibco) supplemented with
heat inactivated 10 % fetal bovine serum (FBS), 100 U/ml
penicillin and 100 mg/ml streptomycin. HCT116 cells were
cultured in McCoy’s 5A (Gibco) medium supplemented
with 10 % FBS, 100 U/ml penicillin and 100 mg/ml strepto-
mycin. All cell lines were cultured at 37 °C with 5 % CO2.
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Additional file 1: Figure S1. Schematic illustration of genome editing by
engineered nucleases. Engineered nucleases like zinc finger nucleases (ZFN),
transcription activator-like effector nuclease (TALEN), and the RNA-guided
clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9
nuclease systems are targeted to specific nucleotide sequences to cause
double strand break (DSB). Cells can repair this DSB either by high-fidelity
homologous recombination (HR) and/or error-prone non-homologous
end-joining (NHEJ) approaches [16]. Homologous recombination event can
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Additional file 2: Figure S2. Strategy for Cas9-mediated generation
of hCDC14A knockout RPE1 cells. (A) Workflow for the construction of
RPE1 hCDC14A-KO cell line. pCW-Cas9 plasmid containing doxycycline
(Dox) inducible spCas9 was lentivirally integrated into RPE1 FRT/T-Rex
cells. (B, C) Successful expression and nuclear localization of Cas9 was
confirmed by indirect-immunofluorescence (B) and western blotting
(C). (D) Junction PCR with forward primer in NeoR cassette and
reverse primer in the genome outside homology arm (as in Fig. 1a)
confirmed successful targeting and insertion of the selection marker.
Exon skipping was confirmed by RT-PCR (primers as in Fig. 3a).
Presence of both wild type and exon-skipped RNA indicated the
targeting of single allele in clones 1 and 20. (PDF 1952 kb)
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